Correct, The trial hype was Leo mentioning a 4Q start with zero facts to back him up. There’s still so much to be done before an actual date that Q4 seems remote now as September slips away. Data needed to be validated with focus on the FDA. So far silence...... Notice Leo never mentioned Aspire which casts more doubt about the June grant application.